Physician profile
Jonathan Barker
NPI 1942201728
$545.82
in general payments reported to CMS, 2019-2025
14 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $45.25 · 2020: $62.32 · 2021: $99.31 · 2022: $59.94 · 2023: $59.60 · 2024: $118 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $279.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $92.66 | 2021-2023 | In.Pact Av |
| Boston Scientific Corporation | $86.38 | 2024-2025 | General - Embolics |
| Stryker Corporation | $69.29 | 2021-2025 | Clottriever Bold Catheter |
| Alphatec Spine, INC | $59.94 | 2022 | |
| Penumbra, INC. | $39.90 | 2024 | Penumbra System |
| Cook Medical LLC | $36.72 | 2024 | Cook |
| Angiodynamics, INC. | $32.01 | 2019 | |
| Medtronic Vascular, INC. | $25.48 | 2020 | |
| Avenu Medical INC. | $22.02 | 2020 | |
| Janssen Pharmaceuticals, INC | $21.87 | 2023 | Xarelto |
| Guerbet LLC | $15.92 | 2023 | Elucirem |
| Cordis US Corp. | $15.57 | 2025 | Precise Pro Rx |
| Covidien LP | $14.82 | 2020 | |
| Depuy Synthes Sales INC. | $13.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.